Citius Pharmaceuticals Inc (CTXR)
0.1345
-0.03
(-18.53%)
USD |
NASDAQ |
Nov 22, 16:00
0.133
0.00 (0.00%)
After-Hours: 19:07
Citius Pharmaceuticals Total Assets (Quarterly): 97.09M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 97.09M |
March 31, 2024 | 90.71M |
December 31, 2023 | 97.40M |
September 30, 2023 | 103.61M |
June 30, 2023 | 110.40M |
March 31, 2023 | 104.24M |
December 31, 2022 | 111.71M |
September 30, 2022 | 114.00M |
June 30, 2022 | 120.32M |
March 31, 2022 | 127.79M |
December 31, 2021 | 137.52M |
September 30, 2021 | 142.43M |
June 30, 2021 | 146.59M |
March 31, 2021 | 134.67M |
December 31, 2020 | 35.31M |
September 30, 2020 | 43.77M |
June 30, 2020 | 38.40M |
March 31, 2020 | 26.49M |
December 31, 2019 | 24.98M |
September 30, 2019 | 36.75M |
June 30, 2019 | 25.54M |
March 31, 2019 | 24.24M |
December 31, 2018 | 28.08M |
September 30, 2018 | 31.05M |
June 30, 2018 | 23.83M |
Date | Value |
---|---|
March 31, 2018 | 26.06M |
December 31, 2017 | 28.47M |
September 30, 2017 | 24.42M |
June 30, 2017 | 21.57M |
March 31, 2017 | 21.33M |
December 31, 2016 | 21.48M |
September 30, 2016 | 21.95M |
June 30, 2016 | 23.01M |
March 31, 2016 | 24.78M |
December 31, 2015 | 0.3469M |
September 30, 2015 | 0.7415M |
June 30, 2015 | 0.9623M |
March 31, 2015 | 0.7658M |
December 31, 2014 | 0.8226M |
September 30, 2014 | 1.558M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.006M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.0001M |
December 31, 2012 | 0.0001M |
September 30, 2012 | 0.0001M |
June 30, 2012 | 0.0002M |
March 31, 2012 | 0.00 |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
24.98M
Minimum
Dec 2019
146.59M
Maximum
Jun 2021
95.13M
Average
104.24M
Median
Mar 2023
Total Assets (Quarterly) Benchmarks
Citius Oncology Inc | -- |
Agilent Technologies Inc | 11.00B |
Merck & Co Inc | 117.53B |
Cara Therapeutics Inc | 51.33M |
Moleculin Biotech Inc | 23.39M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 10.81M |
Shareholders Equity (Quarterly) | 85.68M |